The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the difference between the groups was 16 months so the median time progression for standard of care was 14 months which is pretty much what's what's uh in the literature for the for the the um adaptive therapy group it was 30 months
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
but then we said but of the 20 four patients are now out five years and they're still cycling and this is this is patients with metastatic prostate cancer